Compare · DELL vs OMCL
DELL vs OMCL
Side-by-side comparison of Dell Technologies Inc. (DELL) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DELL and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- DELL is the larger of the two at $256.18B, about 131.0x OMCL ($1.96B).
- Over the past year, DELL is up 255.4% and OMCL is up 35.2% - DELL leads by 220.1 points.
- DELL has been more active in the news (47 items in the past 4 weeks vs 16 for OMCL).
- DELL has more recent analyst coverage (25 ratings vs 24 for OMCL).
- Company
- Dell Technologies Inc.
- Omnicell Inc.
- Price
- $405.76+2.87%
- $42.84-0.40%
- Market cap
- $256.18B
- $1.96B
- 1M return
- +76.37%
- -1.18%
- 1Y return
- +255.36%
- +35.23%
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- 2001
- News (4w)
- 47
- 16
- Recent ratings
- 25
- 24
Dell Technologies Inc.
Dell Technologies Inc. designs, develops, manufactures, markets, sells, and supports Information technology solutions, products, and services worldwide. It operates through three segments: Infrastructure Solutions Group (ISG), Client Solutions Group (CSG), and VMware. The ISG segment provides traditional and next-generation storage solutions; and rack, blade, tower, and hyperscale servers. This segment also offers networking products and services that help its business customers to transform and modernize their infrastructure, mobilize and enrich end-user experiences, and accelerate business applications and processes; attached software and peripherals; and support and deployment, configuration, and extended warranty services. The CSG segment provides desktops, workstations, and notebooks; displays and projectors; attached and third-party software and peripherals, as well as support and deployment, configuration, and extended warranty services. The VMware segment supports and addresses various IT priorities of customers, including accelerating their cloud journey, migrating and modernizing their applications, empowering digital workspaces, transforming networking, and embracing intrinsic security. It enables its customers to digitally transform their operations as they ready their applications, infrastructure, and employees for constantly evolving business needs. This segment also offers cloud-native platform that makes software development and IT operations a strategic advantage for customers. The company also provides information security; cloud software and infrastructure-as-a-service solutions that enable customers to migrate, run, and manage mission-critical applications in cloud-based IT environments; cloud-based integration services; and financial services. The company was formerly known as Denali Holding Inc. and changed its name to Dell Technologies Inc. in August 2016. Dell Technologies Inc. was founded in 1984 and is headquartered in Round Rock, Texas.
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest DELL
- SEC Form 144 filed by Dell Technologies Inc.
- Director Silver Lake Technology Investors V, L.P. converted options into 610 units of Class C Common Stock and sold $257,591 worth of Class C Common Stock (609 units at $422.97) (SEC Form 4)
- Director Silver Lake Partners Iv, L.P. sold $35,684,700 worth of Class C Common Stock (84,365 units at $422.98), disposed of 7,521 units of Class C Common Stock, gifted 7,487 units of Class C Common Stock and converted options into 91,886 units of Class C Common Stock (SEC Form 4)
- Director Silver Lake Technology Investors Iv, L.P. converted options into 1,352 units of Class C Common Stock and sold $571,445 worth of Class C Common Stock (1,351 units at $422.98) (SEC Form 4)
- Director Silver Lake Partners V De (Aiv), L.P. converted options into 49,738 units of Class C Common Stock and sold $14,989,134 worth of Class C Common Stock (35,437 units at $422.98) (SEC Form 4)
- Director Sl Spv-2, L.P. sold $33,092,256 worth of Class C Common Stock (78,236 units at $422.98), disposed of 11,274 units of Class C Common Stock and converted options into 89,510 units of Class C Common Stock (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Dell Technologies Inc.
- SEC Form 144 filed by Dell Technologies Inc.
- Director Silver Lake Technology Investors V, L.P. sold $64,604 worth of Class C Common Stock (141 units at $458.18) (SEC Form 4)
- Director Silver Lake Technology Investors V, L.P. converted options into 1,418 units of Class C Common Stock and sold $561,824 worth of Class C Common Stock (1,280 units at $438.93) (SEC Form 4)
Latest OMCL
- Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
- Director Bousa Edward Peter was granted 4,603 shares, increasing direct ownership by 26% to 22,589 units (SEC Form 4)
- Director Scott Bruce E was granted 4,627 shares, increasing direct ownership by 20% to 27,600 units (SEC Form 4)
- Director Seim Robin Gene was granted 4,845 shares, increasing direct ownership by 10% to 52,198 units (SEC Form 4)
- Director Voynick Eileen J. was granted 4,785 shares, increasing direct ownership by 31% to 20,011 units (SEC Form 4)
- Director Parrish Mark W was granted 4,845 shares, increasing direct ownership by 7% to 70,100 units (SEC Form 4)
- Director Bauer Joanne B was granted 5,027 shares, increasing direct ownership by 11% to 49,922 units (SEC Form 4)
- Director Garrett Mary was granted 5,027 shares, increasing direct ownership by 29% to 22,202 units (SEC Form 4)
- Director Ghoshal Kaushik was granted 4,603 shares, increasing direct ownership by 32% to 19,123 units (SEC Form 4)
- Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026